nodes	percent_of_prediction	percent_of_DWPC	metapath
Voriconazole—PTGS1—Ifosfamide—testicular cancer	0.0984	0.143	CbGbCtD
Voriconazole—CYP3A7—Ifosfamide—testicular cancer	0.0787	0.115	CbGbCtD
Voriconazole—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.0787	0.115	CbGbCtD
Voriconazole—CYP2B6—Ifosfamide—testicular cancer	0.075	0.109	CbGbCtD
Voriconazole—CYP3A5—Ifosfamide—testicular cancer	0.0591	0.0861	CbGbCtD
Voriconazole—CYP2C19—Ifosfamide—testicular cancer	0.0476	0.0694	CbGbCtD
Voriconazole—PTGS1—Etoposide—testicular cancer	0.047	0.0685	CbGbCtD
Voriconazole—CYP2C9—Ifosfamide—testicular cancer	0.0396	0.0577	CbGbCtD
Voriconazole—CYP2B6—Cisplatin—testicular cancer	0.0365	0.0531	CbGbCtD
Voriconazole—CYP3A5—Etoposide—testicular cancer	0.0282	0.0411	CbGbCtD
Voriconazole—CYP2B6—Doxorubicin—testicular cancer	0.0244	0.0356	CbGbCtD
Voriconazole—CYP3A4—Ifosfamide—testicular cancer	0.023	0.0336	CbGbCtD
Voriconazole—CYP2C9—Cisplatin—testicular cancer	0.0193	0.0281	CbGbCtD
Voriconazole—CYP3A4—Vinblastine—testicular cancer	0.0122	0.0178	CbGbCtD
Voriconazole—CYP3A4—Etoposide—testicular cancer	0.011	0.016	CbGbCtD
Voriconazole—CYP3A4—Doxorubicin—testicular cancer	0.00751	0.0109	CbGbCtD
Voriconazole—Hepatitis—Epirubicin—testicular cancer	0.000109	0.000347	CcSEcCtD
Voriconazole—Eye disorder—Methotrexate—testicular cancer	0.000109	0.000347	CcSEcCtD
Voriconazole—Tinnitus—Methotrexate—testicular cancer	0.000108	0.000346	CcSEcCtD
Voriconazole—Hypoaesthesia—Epirubicin—testicular cancer	0.000108	0.000345	CcSEcCtD
Voriconazole—Asthenia—Cisplatin—testicular cancer	0.000108	0.000344	CcSEcCtD
Voriconazole—Pharyngitis—Epirubicin—testicular cancer	0.000108	0.000344	CcSEcCtD
Voriconazole—Cardiac disorder—Methotrexate—testicular cancer	0.000108	0.000344	CcSEcCtD
Voriconazole—Sweating—Doxorubicin—testicular cancer	0.000108	0.000343	CcSEcCtD
Voriconazole—Urinary tract disorder—Epirubicin—testicular cancer	0.000107	0.000343	CcSEcCtD
Voriconazole—Oedema peripheral—Epirubicin—testicular cancer	0.000107	0.000342	CcSEcCtD
Voriconazole—Haematuria—Doxorubicin—testicular cancer	0.000107	0.000341	CcSEcCtD
Voriconazole—Connective tissue disorder—Epirubicin—testicular cancer	0.000107	0.000341	CcSEcCtD
Voriconazole—Urethral disorder—Epirubicin—testicular cancer	0.000107	0.00034	CcSEcCtD
Voriconazole—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000106	0.000338	CcSEcCtD
Voriconazole—Epistaxis—Doxorubicin—testicular cancer	0.000106	0.000337	CcSEcCtD
Voriconazole—Angiopathy—Methotrexate—testicular cancer	0.000106	0.000336	CcSEcCtD
Voriconazole—Sinusitis—Doxorubicin—testicular cancer	0.000105	0.000336	CcSEcCtD
Voriconazole—Immune system disorder—Methotrexate—testicular cancer	0.000105	0.000335	CcSEcCtD
Voriconazole—Visual impairment—Epirubicin—testicular cancer	0.000105	0.000334	CcSEcCtD
Voriconazole—Mediastinal disorder—Methotrexate—testicular cancer	0.000105	0.000334	CcSEcCtD
Voriconazole—Agranulocytosis—Doxorubicin—testicular cancer	0.000105	0.000334	CcSEcCtD
Voriconazole—Chills—Methotrexate—testicular cancer	0.000104	0.000333	CcSEcCtD
Voriconazole—Nausea—Ifosfamide—testicular cancer	0.000104	0.000331	CcSEcCtD
Voriconazole—Diarrhoea—Cisplatin—testicular cancer	0.000103	0.000328	CcSEcCtD
Voriconazole—Erythema multiforme—Epirubicin—testicular cancer	0.000103	0.000328	CcSEcCtD
Voriconazole—Alopecia—Methotrexate—testicular cancer	0.000103	0.000328	CcSEcCtD
Voriconazole—Bradycardia—Doxorubicin—testicular cancer	0.000103	0.000327	CcSEcCtD
Voriconazole—Mental disorder—Methotrexate—testicular cancer	0.000102	0.000325	CcSEcCtD
Voriconazole—Eye disorder—Epirubicin—testicular cancer	0.000102	0.000324	CcSEcCtD
Voriconazole—Hypersensitivity—Etoposide—testicular cancer	0.000102	0.000324	CcSEcCtD
Voriconazole—Tinnitus—Epirubicin—testicular cancer	0.000101	0.000324	CcSEcCtD
Voriconazole—Erythema—Methotrexate—testicular cancer	0.000101	0.000323	CcSEcCtD
Voriconazole—Malnutrition—Methotrexate—testicular cancer	0.000101	0.000323	CcSEcCtD
Voriconazole—Flushing—Epirubicin—testicular cancer	0.000101	0.000322	CcSEcCtD
Voriconazole—Cardiac disorder—Epirubicin—testicular cancer	0.000101	0.000322	CcSEcCtD
Voriconazole—Rhinitis—Doxorubicin—testicular cancer	0.000101	0.000322	CcSEcCtD
Voriconazole—Hepatitis—Doxorubicin—testicular cancer	0.000101	0.000321	CcSEcCtD
Voriconazole—Hypoaesthesia—Doxorubicin—testicular cancer	0.0001	0.000319	CcSEcCtD
Voriconazole—Pharyngitis—Doxorubicin—testicular cancer	0.0001	0.000319	CcSEcCtD
Voriconazole—Urinary tract disorder—Doxorubicin—testicular cancer	9.95e-05	0.000317	CcSEcCtD
Voriconazole—Oedema peripheral—Doxorubicin—testicular cancer	9.92e-05	0.000316	CcSEcCtD
Voriconazole—Dysgeusia—Methotrexate—testicular cancer	9.91e-05	0.000316	CcSEcCtD
Voriconazole—Asthenia—Etoposide—testicular cancer	9.9e-05	0.000316	CcSEcCtD
Voriconazole—Connective tissue disorder—Doxorubicin—testicular cancer	9.9e-05	0.000316	CcSEcCtD
Voriconazole—Angiopathy—Epirubicin—testicular cancer	9.88e-05	0.000315	CcSEcCtD
Voriconazole—Urethral disorder—Doxorubicin—testicular cancer	9.87e-05	0.000315	CcSEcCtD
Voriconazole—Immune system disorder—Epirubicin—testicular cancer	9.83e-05	0.000313	CcSEcCtD
Voriconazole—Mediastinal disorder—Epirubicin—testicular cancer	9.81e-05	0.000313	CcSEcCtD
Voriconazole—Back pain—Methotrexate—testicular cancer	9.79e-05	0.000312	CcSEcCtD
Voriconazole—Chills—Epirubicin—testicular cancer	9.77e-05	0.000311	CcSEcCtD
Voriconazole—Pruritus—Etoposide—testicular cancer	9.76e-05	0.000311	CcSEcCtD
Voriconazole—Arrhythmia—Epirubicin—testicular cancer	9.72e-05	0.00031	CcSEcCtD
Voriconazole—Visual impairment—Doxorubicin—testicular cancer	9.71e-05	0.000309	CcSEcCtD
Voriconazole—Alopecia—Epirubicin—testicular cancer	9.62e-05	0.000307	CcSEcCtD
Voriconazole—Vomiting—Cisplatin—testicular cancer	9.57e-05	0.000305	CcSEcCtD
Voriconazole—Vision blurred—Methotrexate—testicular cancer	9.54e-05	0.000304	CcSEcCtD
Voriconazole—Mental disorder—Epirubicin—testicular cancer	9.54e-05	0.000304	CcSEcCtD
Voriconazole—Erythema multiforme—Doxorubicin—testicular cancer	9.52e-05	0.000304	CcSEcCtD
Voriconazole—Rash—Cisplatin—testicular cancer	9.49e-05	0.000303	CcSEcCtD
Voriconazole—Dermatitis—Cisplatin—testicular cancer	9.49e-05	0.000302	CcSEcCtD
Voriconazole—Erythema—Epirubicin—testicular cancer	9.48e-05	0.000302	CcSEcCtD
Voriconazole—Malnutrition—Epirubicin—testicular cancer	9.48e-05	0.000302	CcSEcCtD
Voriconazole—Diarrhoea—Etoposide—testicular cancer	9.44e-05	0.000301	CcSEcCtD
Voriconazole—Eye disorder—Doxorubicin—testicular cancer	9.41e-05	0.0003	CcSEcCtD
Voriconazole—Ill-defined disorder—Methotrexate—testicular cancer	9.39e-05	0.0003	CcSEcCtD
Voriconazole—Tinnitus—Doxorubicin—testicular cancer	9.39e-05	0.000299	CcSEcCtD
Voriconazole—Anaemia—Methotrexate—testicular cancer	9.36e-05	0.000298	CcSEcCtD
Voriconazole—Cardiac disorder—Doxorubicin—testicular cancer	9.35e-05	0.000298	CcSEcCtD
Voriconazole—Flushing—Doxorubicin—testicular cancer	9.35e-05	0.000298	CcSEcCtD
Voriconazole—Flatulence—Epirubicin—testicular cancer	9.34e-05	0.000298	CcSEcCtD
Voriconazole—Dysgeusia—Epirubicin—testicular cancer	9.28e-05	0.000296	CcSEcCtD
Voriconazole—Back pain—Epirubicin—testicular cancer	9.17e-05	0.000292	CcSEcCtD
Voriconazole—Angiopathy—Doxorubicin—testicular cancer	9.14e-05	0.000291	CcSEcCtD
Voriconazole—Malaise—Methotrexate—testicular cancer	9.13e-05	0.000291	CcSEcCtD
Voriconazole—Dizziness—Etoposide—testicular cancer	9.12e-05	0.000291	CcSEcCtD
Voriconazole—Muscle spasms—Epirubicin—testicular cancer	9.11e-05	0.00029	CcSEcCtD
Voriconazole—Immune system disorder—Doxorubicin—testicular cancer	9.1e-05	0.00029	CcSEcCtD
Voriconazole—Vertigo—Methotrexate—testicular cancer	9.1e-05	0.00029	CcSEcCtD
Voriconazole—Mediastinal disorder—Doxorubicin—testicular cancer	9.08e-05	0.000289	CcSEcCtD
Voriconazole—Leukopenia—Methotrexate—testicular cancer	9.06e-05	0.000289	CcSEcCtD
Voriconazole—Chills—Doxorubicin—testicular cancer	9.04e-05	0.000288	CcSEcCtD
Voriconazole—Arrhythmia—Doxorubicin—testicular cancer	9e-05	0.000287	CcSEcCtD
Voriconazole—Nausea—Cisplatin—testicular cancer	8.94e-05	0.000285	CcSEcCtD
Voriconazole—Vision blurred—Epirubicin—testicular cancer	8.93e-05	0.000285	CcSEcCtD
Voriconazole—Alopecia—Doxorubicin—testicular cancer	8.9e-05	0.000284	CcSEcCtD
Voriconazole—Cough—Methotrexate—testicular cancer	8.84e-05	0.000282	CcSEcCtD
Voriconazole—Mental disorder—Doxorubicin—testicular cancer	8.82e-05	0.000281	CcSEcCtD
Voriconazole—Ill-defined disorder—Epirubicin—testicular cancer	8.79e-05	0.00028	CcSEcCtD
Voriconazole—Convulsion—Methotrexate—testicular cancer	8.77e-05	0.00028	CcSEcCtD
Voriconazole—Vomiting—Etoposide—testicular cancer	8.77e-05	0.00028	CcSEcCtD
Voriconazole—Erythema—Doxorubicin—testicular cancer	8.77e-05	0.00028	CcSEcCtD
Voriconazole—Malnutrition—Doxorubicin—testicular cancer	8.77e-05	0.00028	CcSEcCtD
Voriconazole—Anaemia—Epirubicin—testicular cancer	8.76e-05	0.000279	CcSEcCtD
Voriconazole—Agitation—Epirubicin—testicular cancer	8.71e-05	0.000278	CcSEcCtD
Voriconazole—Rash—Etoposide—testicular cancer	8.7e-05	0.000277	CcSEcCtD
Voriconazole—Dermatitis—Etoposide—testicular cancer	8.69e-05	0.000277	CcSEcCtD
Voriconazole—Headache—Etoposide—testicular cancer	8.64e-05	0.000276	CcSEcCtD
Voriconazole—Flatulence—Doxorubicin—testicular cancer	8.64e-05	0.000275	CcSEcCtD
Voriconazole—Arthralgia—Methotrexate—testicular cancer	8.62e-05	0.000275	CcSEcCtD
Voriconazole—Chest pain—Methotrexate—testicular cancer	8.62e-05	0.000275	CcSEcCtD
Voriconazole—Myalgia—Methotrexate—testicular cancer	8.62e-05	0.000275	CcSEcCtD
Voriconazole—Dysgeusia—Doxorubicin—testicular cancer	8.59e-05	0.000274	CcSEcCtD
Voriconazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	8.56e-05	0.000273	CcSEcCtD
Voriconazole—Malaise—Epirubicin—testicular cancer	8.54e-05	0.000272	CcSEcCtD
Voriconazole—Discomfort—Methotrexate—testicular cancer	8.52e-05	0.000272	CcSEcCtD
Voriconazole—Vertigo—Epirubicin—testicular cancer	8.51e-05	0.000271	CcSEcCtD
Voriconazole—Syncope—Epirubicin—testicular cancer	8.5e-05	0.000271	CcSEcCtD
Voriconazole—Leukopenia—Epirubicin—testicular cancer	8.48e-05	0.00027	CcSEcCtD
Voriconazole—Back pain—Doxorubicin—testicular cancer	8.48e-05	0.00027	CcSEcCtD
Voriconazole—Muscle spasms—Doxorubicin—testicular cancer	8.43e-05	0.000269	CcSEcCtD
Voriconazole—Palpitations—Epirubicin—testicular cancer	8.37e-05	0.000267	CcSEcCtD
Voriconazole—Confusional state—Methotrexate—testicular cancer	8.33e-05	0.000266	CcSEcCtD
Voriconazole—Loss of consciousness—Epirubicin—testicular cancer	8.33e-05	0.000266	CcSEcCtD
Voriconazole—Cough—Epirubicin—testicular cancer	8.27e-05	0.000264	CcSEcCtD
Voriconazole—Anaphylactic shock—Methotrexate—testicular cancer	8.26e-05	0.000263	CcSEcCtD
Voriconazole—Vision blurred—Doxorubicin—testicular cancer	8.26e-05	0.000263	CcSEcCtD
Voriconazole—Convulsion—Epirubicin—testicular cancer	8.21e-05	0.000262	CcSEcCtD
Voriconazole—Infection—Methotrexate—testicular cancer	8.21e-05	0.000262	CcSEcCtD
Voriconazole—Nausea—Etoposide—testicular cancer	8.19e-05	0.000261	CcSEcCtD
Voriconazole—Hypertension—Epirubicin—testicular cancer	8.18e-05	0.000261	CcSEcCtD
Voriconazole—Ill-defined disorder—Doxorubicin—testicular cancer	8.13e-05	0.000259	CcSEcCtD
Voriconazole—Nervous system disorder—Methotrexate—testicular cancer	8.1e-05	0.000258	CcSEcCtD
Voriconazole—Anaemia—Doxorubicin—testicular cancer	8.1e-05	0.000258	CcSEcCtD
Voriconazole—Thrombocytopenia—Methotrexate—testicular cancer	8.09e-05	0.000258	CcSEcCtD
Voriconazole—Chest pain—Epirubicin—testicular cancer	8.07e-05	0.000257	CcSEcCtD
Voriconazole—Arthralgia—Epirubicin—testicular cancer	8.07e-05	0.000257	CcSEcCtD
Voriconazole—Myalgia—Epirubicin—testicular cancer	8.07e-05	0.000257	CcSEcCtD
Voriconazole—Agitation—Doxorubicin—testicular cancer	8.06e-05	0.000257	CcSEcCtD
Voriconazole—Anxiety—Epirubicin—testicular cancer	8.04e-05	0.000256	CcSEcCtD
Voriconazole—Skin disorder—Methotrexate—testicular cancer	8.03e-05	0.000256	CcSEcCtD
Voriconazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	8.01e-05	0.000255	CcSEcCtD
Voriconazole—Hyperhidrosis—Methotrexate—testicular cancer	7.99e-05	0.000255	CcSEcCtD
Voriconazole—Discomfort—Epirubicin—testicular cancer	7.97e-05	0.000254	CcSEcCtD
Voriconazole—Malaise—Doxorubicin—testicular cancer	7.91e-05	0.000252	CcSEcCtD
Voriconazole—Dry mouth—Epirubicin—testicular cancer	7.89e-05	0.000252	CcSEcCtD
Voriconazole—Vertigo—Doxorubicin—testicular cancer	7.88e-05	0.000251	CcSEcCtD
Voriconazole—Anorexia—Methotrexate—testicular cancer	7.88e-05	0.000251	CcSEcCtD
Voriconazole—Syncope—Doxorubicin—testicular cancer	7.86e-05	0.000251	CcSEcCtD
Voriconazole—Leukopenia—Doxorubicin—testicular cancer	7.85e-05	0.00025	CcSEcCtD
Voriconazole—Confusional state—Epirubicin—testicular cancer	7.8e-05	0.000249	CcSEcCtD
Voriconazole—Palpitations—Doxorubicin—testicular cancer	7.75e-05	0.000247	CcSEcCtD
Voriconazole—Anaphylactic shock—Epirubicin—testicular cancer	7.73e-05	0.000247	CcSEcCtD
Voriconazole—Oedema—Epirubicin—testicular cancer	7.73e-05	0.000247	CcSEcCtD
Voriconazole—Hypotension—Methotrexate—testicular cancer	7.72e-05	0.000246	CcSEcCtD
Voriconazole—Loss of consciousness—Doxorubicin—testicular cancer	7.71e-05	0.000246	CcSEcCtD
Voriconazole—Infection—Epirubicin—testicular cancer	7.68e-05	0.000245	CcSEcCtD
Voriconazole—Cough—Doxorubicin—testicular cancer	7.65e-05	0.000244	CcSEcCtD
Voriconazole—Shock—Epirubicin—testicular cancer	7.61e-05	0.000243	CcSEcCtD
Voriconazole—Convulsion—Doxorubicin—testicular cancer	7.6e-05	0.000242	CcSEcCtD
Voriconazole—Nervous system disorder—Epirubicin—testicular cancer	7.58e-05	0.000242	CcSEcCtD
Voriconazole—Thrombocytopenia—Epirubicin—testicular cancer	7.57e-05	0.000241	CcSEcCtD
Voriconazole—Hypertension—Doxorubicin—testicular cancer	7.57e-05	0.000241	CcSEcCtD
Voriconazole—Tachycardia—Epirubicin—testicular cancer	7.55e-05	0.000241	CcSEcCtD
Voriconazole—Musculoskeletal discomfort—Methotrexate—testicular cancer	7.53e-05	0.00024	CcSEcCtD
Voriconazole—Skin disorder—Epirubicin—testicular cancer	7.51e-05	0.000239	CcSEcCtD
Voriconazole—Hyperhidrosis—Epirubicin—testicular cancer	7.48e-05	0.000238	CcSEcCtD
Voriconazole—Insomnia—Methotrexate—testicular cancer	7.47e-05	0.000238	CcSEcCtD
Voriconazole—Arthralgia—Doxorubicin—testicular cancer	7.46e-05	0.000238	CcSEcCtD
Voriconazole—Myalgia—Doxorubicin—testicular cancer	7.46e-05	0.000238	CcSEcCtD
Voriconazole—Chest pain—Doxorubicin—testicular cancer	7.46e-05	0.000238	CcSEcCtD
Voriconazole—Anxiety—Doxorubicin—testicular cancer	7.44e-05	0.000237	CcSEcCtD
Voriconazole—Paraesthesia—Methotrexate—testicular cancer	7.42e-05	0.000237	CcSEcCtD
Voriconazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	7.41e-05	0.000236	CcSEcCtD
Voriconazole—Discomfort—Doxorubicin—testicular cancer	7.37e-05	0.000235	CcSEcCtD
Voriconazole—Anorexia—Epirubicin—testicular cancer	7.37e-05	0.000235	CcSEcCtD
Voriconazole—Dyspnoea—Methotrexate—testicular cancer	7.37e-05	0.000235	CcSEcCtD
Voriconazole—Somnolence—Methotrexate—testicular cancer	7.35e-05	0.000234	CcSEcCtD
Voriconazole—Dry mouth—Doxorubicin—testicular cancer	7.3e-05	0.000233	CcSEcCtD
Voriconazole—Dyspepsia—Methotrexate—testicular cancer	7.27e-05	0.000232	CcSEcCtD
Voriconazole—Hypotension—Epirubicin—testicular cancer	7.23e-05	0.00023	CcSEcCtD
Voriconazole—Confusional state—Doxorubicin—testicular cancer	7.21e-05	0.00023	CcSEcCtD
Voriconazole—Decreased appetite—Methotrexate—testicular cancer	7.18e-05	0.000229	CcSEcCtD
Voriconazole—Anaphylactic shock—Doxorubicin—testicular cancer	7.16e-05	0.000228	CcSEcCtD
Voriconazole—Oedema—Doxorubicin—testicular cancer	7.16e-05	0.000228	CcSEcCtD
Voriconazole—Gastrointestinal disorder—Methotrexate—testicular cancer	7.13e-05	0.000227	CcSEcCtD
Voriconazole—Infection—Doxorubicin—testicular cancer	7.11e-05	0.000227	CcSEcCtD
Voriconazole—Pain—Methotrexate—testicular cancer	7.07e-05	0.000225	CcSEcCtD
Voriconazole—Musculoskeletal discomfort—Epirubicin—testicular cancer	7.05e-05	0.000225	CcSEcCtD
Voriconazole—Shock—Doxorubicin—testicular cancer	7.04e-05	0.000224	CcSEcCtD
Voriconazole—Nervous system disorder—Doxorubicin—testicular cancer	7.02e-05	0.000224	CcSEcCtD
Voriconazole—Thrombocytopenia—Doxorubicin—testicular cancer	7.01e-05	0.000223	CcSEcCtD
Voriconazole—Insomnia—Epirubicin—testicular cancer	6.99e-05	0.000223	CcSEcCtD
Voriconazole—Tachycardia—Doxorubicin—testicular cancer	6.98e-05	0.000223	CcSEcCtD
Voriconazole—Skin disorder—Doxorubicin—testicular cancer	6.95e-05	0.000222	CcSEcCtD
Voriconazole—Paraesthesia—Epirubicin—testicular cancer	6.94e-05	0.000221	CcSEcCtD
Voriconazole—Hyperhidrosis—Doxorubicin—testicular cancer	6.92e-05	0.000221	CcSEcCtD
Voriconazole—Dyspnoea—Epirubicin—testicular cancer	6.89e-05	0.00022	CcSEcCtD
Voriconazole—Somnolence—Epirubicin—testicular cancer	6.87e-05	0.000219	CcSEcCtD
Voriconazole—Anorexia—Doxorubicin—testicular cancer	6.82e-05	0.000217	CcSEcCtD
Voriconazole—Feeling abnormal—Methotrexate—testicular cancer	6.81e-05	0.000217	CcSEcCtD
Voriconazole—Dyspepsia—Epirubicin—testicular cancer	6.81e-05	0.000217	CcSEcCtD
Voriconazole—Gastrointestinal pain—Methotrexate—testicular cancer	6.76e-05	0.000215	CcSEcCtD
Voriconazole—Decreased appetite—Epirubicin—testicular cancer	6.72e-05	0.000214	CcSEcCtD
Voriconazole—Hypotension—Doxorubicin—testicular cancer	6.69e-05	0.000213	CcSEcCtD
Voriconazole—Gastrointestinal disorder—Epirubicin—testicular cancer	6.68e-05	0.000213	CcSEcCtD
Voriconazole—Constipation—Epirubicin—testicular cancer	6.61e-05	0.000211	CcSEcCtD
Voriconazole—Pain—Epirubicin—testicular cancer	6.61e-05	0.000211	CcSEcCtD
Voriconazole—Urticaria—Methotrexate—testicular cancer	6.56e-05	0.000209	CcSEcCtD
Voriconazole—Body temperature increased—Methotrexate—testicular cancer	6.53e-05	0.000208	CcSEcCtD
Voriconazole—Abdominal pain—Methotrexate—testicular cancer	6.53e-05	0.000208	CcSEcCtD
Voriconazole—Musculoskeletal discomfort—Doxorubicin—testicular cancer	6.52e-05	0.000208	CcSEcCtD
Voriconazole—Insomnia—Doxorubicin—testicular cancer	6.47e-05	0.000206	CcSEcCtD
Voriconazole—Paraesthesia—Doxorubicin—testicular cancer	6.42e-05	0.000205	CcSEcCtD
Voriconazole—Dyspnoea—Doxorubicin—testicular cancer	6.38e-05	0.000203	CcSEcCtD
Voriconazole—Feeling abnormal—Epirubicin—testicular cancer	6.37e-05	0.000203	CcSEcCtD
Voriconazole—Somnolence—Doxorubicin—testicular cancer	6.36e-05	0.000203	CcSEcCtD
Voriconazole—Gastrointestinal pain—Epirubicin—testicular cancer	6.32e-05	0.000202	CcSEcCtD
Voriconazole—Dyspepsia—Doxorubicin—testicular cancer	6.3e-05	0.000201	CcSEcCtD
Voriconazole—Decreased appetite—Doxorubicin—testicular cancer	6.22e-05	0.000198	CcSEcCtD
Voriconazole—Gastrointestinal disorder—Doxorubicin—testicular cancer	6.18e-05	0.000197	CcSEcCtD
Voriconazole—Urticaria—Epirubicin—testicular cancer	6.14e-05	0.000196	CcSEcCtD
Voriconazole—Pain—Doxorubicin—testicular cancer	6.12e-05	0.000195	CcSEcCtD
Voriconazole—Constipation—Doxorubicin—testicular cancer	6.12e-05	0.000195	CcSEcCtD
Voriconazole—Body temperature increased—Epirubicin—testicular cancer	6.11e-05	0.000195	CcSEcCtD
Voriconazole—Abdominal pain—Epirubicin—testicular cancer	6.11e-05	0.000195	CcSEcCtD
Voriconazole—Hypersensitivity—Methotrexate—testicular cancer	6.09e-05	0.000194	CcSEcCtD
Voriconazole—Asthenia—Methotrexate—testicular cancer	5.93e-05	0.000189	CcSEcCtD
Voriconazole—Feeling abnormal—Doxorubicin—testicular cancer	5.9e-05	0.000188	CcSEcCtD
Voriconazole—Gastrointestinal pain—Doxorubicin—testicular cancer	5.85e-05	0.000187	CcSEcCtD
Voriconazole—Pruritus—Methotrexate—testicular cancer	5.85e-05	0.000186	CcSEcCtD
Voriconazole—Hypersensitivity—Epirubicin—testicular cancer	5.7e-05	0.000182	CcSEcCtD
Voriconazole—Urticaria—Doxorubicin—testicular cancer	5.68e-05	0.000181	CcSEcCtD
Voriconazole—Abdominal pain—Doxorubicin—testicular cancer	5.66e-05	0.00018	CcSEcCtD
Voriconazole—Body temperature increased—Doxorubicin—testicular cancer	5.66e-05	0.00018	CcSEcCtD
Voriconazole—Diarrhoea—Methotrexate—testicular cancer	5.65e-05	0.00018	CcSEcCtD
Voriconazole—Asthenia—Epirubicin—testicular cancer	5.55e-05	0.000177	CcSEcCtD
Voriconazole—Pruritus—Epirubicin—testicular cancer	5.47e-05	0.000174	CcSEcCtD
Voriconazole—Dizziness—Methotrexate—testicular cancer	5.46e-05	0.000174	CcSEcCtD
Voriconazole—Diarrhoea—Epirubicin—testicular cancer	5.29e-05	0.000169	CcSEcCtD
Voriconazole—Hypersensitivity—Doxorubicin—testicular cancer	5.27e-05	0.000168	CcSEcCtD
Voriconazole—Vomiting—Methotrexate—testicular cancer	5.25e-05	0.000168	CcSEcCtD
Voriconazole—Rash—Methotrexate—testicular cancer	5.21e-05	0.000166	CcSEcCtD
Voriconazole—Dermatitis—Methotrexate—testicular cancer	5.21e-05	0.000166	CcSEcCtD
Voriconazole—Headache—Methotrexate—testicular cancer	5.18e-05	0.000165	CcSEcCtD
Voriconazole—Asthenia—Doxorubicin—testicular cancer	5.13e-05	0.000164	CcSEcCtD
Voriconazole—Dizziness—Epirubicin—testicular cancer	5.11e-05	0.000163	CcSEcCtD
Voriconazole—Pruritus—Doxorubicin—testicular cancer	5.06e-05	0.000161	CcSEcCtD
Voriconazole—Vomiting—Epirubicin—testicular cancer	4.92e-05	0.000157	CcSEcCtD
Voriconazole—Nausea—Methotrexate—testicular cancer	4.91e-05	0.000156	CcSEcCtD
Voriconazole—Diarrhoea—Doxorubicin—testicular cancer	4.9e-05	0.000156	CcSEcCtD
Voriconazole—Rash—Epirubicin—testicular cancer	4.88e-05	0.000155	CcSEcCtD
Voriconazole—Dermatitis—Epirubicin—testicular cancer	4.87e-05	0.000155	CcSEcCtD
Voriconazole—Headache—Epirubicin—testicular cancer	4.84e-05	0.000154	CcSEcCtD
Voriconazole—Dizziness—Doxorubicin—testicular cancer	4.73e-05	0.000151	CcSEcCtD
Voriconazole—Nausea—Epirubicin—testicular cancer	4.59e-05	0.000146	CcSEcCtD
Voriconazole—Vomiting—Doxorubicin—testicular cancer	4.55e-05	0.000145	CcSEcCtD
Voriconazole—Rash—Doxorubicin—testicular cancer	4.51e-05	0.000144	CcSEcCtD
Voriconazole—Dermatitis—Doxorubicin—testicular cancer	4.51e-05	0.000144	CcSEcCtD
Voriconazole—Headache—Doxorubicin—testicular cancer	4.48e-05	0.000143	CcSEcCtD
Voriconazole—Nausea—Doxorubicin—testicular cancer	4.25e-05	0.000136	CcSEcCtD
